Revumenib Monotherapy in KMT2Ar RR AL MED-REV-240021


monotherapy; kmt2a; kmt2ar; kmt2a translocation; kmt2a translocated; AUGMENT-101; NCT04065399; relapsed; refractory; all; aml; myeloid; lymphocytic; lymphoblastic